Asset Allocation

As of September 30, 2026.
Type % Net
Cash 1.90%
Stock 65.84%
Bond 32.07%
Convertible 0.00%
Preferred 0.00%
Other 0.18%
View Asset Allocation
Start Trial

Market Capitalization

As of September 30, 2026
Large 78.39%
Mid 11.79%
Small 9.82%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.47%    % Emerging Markets: 0.00%    % Unidentified Markets: 1.53%

Americas 94.67%
94.67%
Canada 1.29%
United States 93.38%
0.00%
As of September 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 2.87%
United Kingdom 1.85%
1.02%
France 0.13%
Ireland 0.12%
Netherlands 0.65%
Switzerland 0.00%
0.00%
0.00%
Saudi Arabia 0.00%
United Arab Emirates 0.00%
Greater Asia 0.93%
Japan 0.00%
0.13%
Australia 0.13%
0.80%
Hong Kong 0.68%
Singapore 0.12%
0.00%
Unidentified Region 1.53%

Bond Credit Quality Exposure

AAA 0.69%
AA 45.82%
A 12.21%
BBB 17.17%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.01%
Not Available 24.11%
Short Term 0.00%
As of September 30, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
21.13%
Materials
0.00%
Consumer Discretionary
9.81%
Financials
11.31%
Real Estate
0.00%
Sensitive
69.72%
Communication Services
14.22%
Energy
1.11%
Industrials
3.94%
Information Technology
50.45%
Defensive
9.15%
Consumer Staples
0.00%
Health Care
9.15%
Utilities
0.00%
Not Classified
0.00%
Non Classified Equity
0.00%
As of September 30, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of September 30, 2026
Type % Net
Government 43.02%
Corporate 31.41%
Securitized 22.60%
Municipal 2.55%
Other 0.42%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
9.03%
Less than 1 Year
9.03%
Intermediate
60.63%
1 to 3 Years
8.60%
3 to 5 Years
12.77%
5 to 10 Years
39.27%
Long Term
30.32%
10 to 20 Years
7.33%
20 to 30 Years
22.92%
Over 30 Years
0.07%
Other
0.02%
As of September 30, 2026
View Bond Maturity Exposure
Start Trial